1. Home
  2. SCPH vs OIA Comparison

SCPH vs OIA Comparison

Compare SCPH & OIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
    SELLHOLDBUYas of 2 days ago
  • OIA
    SELLHOLDBUYas of 2 days ago
  • Stock Information
  • Founded
  • SCPH 2013
  • OIA 1988
  • Country
  • SCPH United States
  • OIA United States
  • Employees
  • SCPH N/A
  • OIA N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • OIA Finance Companies
  • Sector
  • SCPH Health Care
  • OIA Finance
  • Exchange
  • SCPH Nasdaq
  • OIA Nasdaq
  • Market Cap
  • SCPH 179.6M
  • OIA 279.3M
  • IPO Year
  • SCPH 2017
  • OIA N/A
  • Fundamental
  • Price
  • SCPH $3.59
  • OIA $6.05
  • Analyst Decision
  • SCPH Strong Buy
  • OIA
  • Analyst Count
  • SCPH 2
  • OIA 0
  • Target Price
  • SCPH $15.00
  • OIA N/A
  • AVG Volume (30 Days)
  • SCPH 499.2K
  • OIA 97.9K
  • Earning Date
  • SCPH 11-13-2024
  • OIA 01-01-0001
  • Dividend Yield
  • SCPH N/A
  • OIA 4.88%
  • EPS Growth
  • SCPH N/A
  • OIA N/A
  • EPS
  • SCPH N/A
  • OIA N/A
  • Revenue
  • SCPH $30,278,000.00
  • OIA N/A
  • Revenue This Year
  • SCPH $172.64
  • OIA N/A
  • Revenue Next Year
  • SCPH $131.43
  • OIA N/A
  • P/E Ratio
  • SCPH N/A
  • OIA N/A
  • Revenue Growth
  • SCPH 303.87
  • OIA N/A
  • 52 Week Low
  • SCPH $3.08
  • OIA $4.93
  • 52 Week High
  • SCPH $6.60
  • OIA $6.72
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 54.21
  • OIA 40.67
  • Support Level
  • SCPH $3.33
  • OIA $5.81
  • Resistance Level
  • SCPH $3.70
  • OIA $6.01
  • Average True Range (ATR)
  • SCPH 0.18
  • OIA 0.12
  • MACD
  • SCPH 0.05
  • OIA 0.00
  • Stochastic Oscillator
  • SCPH 81.36
  • OIA 44.17

Stock Price Comparison Chart: SCPH vs OIA

SCPH
OIA
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250123456789101112SCPH VS OIA

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

About OIA Invesco Municipal Income Opportunities Trust

Invesco Muni Income Opps Trust operates as a diversified closed-end management investment company. Its investment objective is to provide a high level of current income which is exempt from federal income tax.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use